The global Coronary Stents Market is projected to reach a substantial USD 51.2 billion by 2032, reflecting a steady growth ...

A “bioadaptive” stent might circumvent the slow accumulation of target lesion failure that has been a consistent weakness of ...

Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good day, everyone, and welcome to the InspireMD Third Quarter ...

Stents are, of course, used in other scenarios to open large arteries. The new stent, with its unique pinched-in-the-middle ...

Solaris Endovascular, Inc. proudly announces its formation to develop solutions for Dialysis Access and Peripheral Artery disease (PAD). Solaris Endovascular develops evidence-based technologies, ...

Unlike tube-shaped stents used to open clogged arteries, the hourglass-shaped stent narrows in the middle. The different ...

Subsequently, the Novoste Corporation, located in Norcross, Georgia—which started conducting BetaCath clinical trials—began ...

A study at Mayo Clinic suggests that an hourglass-shaped stent could improve blood flow and ease severe and reoccurring chest ...

Summary: The use of balloon angioplasty with or without coronary artery stenting is limited by the phenomenon of in-stent restenosis (ISR). Until very recently, most efforts to overcome ISR had ...